416154 Sigma-AldrichPre-mRNA Splicing Inhibitor, Isoginkgetin - CAS 548-19-6 - Calbiochem
Pre-mRNA Splicing Inhibitor, Isoginkgetin, CAS 548-19-6, is a cell-permeable inhibitor of pre-mRNA splicing. Blocks spliceosome-mediated splicing process at the pre-spliceosome/A complex stage.
More>> Pre-mRNA Splicing Inhibitor, Isoginkgetin, CAS 548-19-6, is a cell-permeable inhibitor of pre-mRNA splicing. Blocks spliceosome-mediated splicing process at the pre-spliceosome/A complex stage. Less<<Synonyms: 8-(5-(5,7-Dihydroxy-4-oxo-4H-chromen-2-yl)-2-methoxyphenyl)-5,7-dihydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one
Recommended Products
Overview
Replacement Information |
---|
Key Specifications Table
CAS # | Empirical Formula |
---|---|
548-19-6 | C₃₂H₂₂O₁₀ |
Products
Catalog Number | Packaging | Qty/Pack | |
---|---|---|---|
416154-10MG | Glass bottle | 10 mg |
References | |
---|---|
References | Kim, H.Y., et al. 2008. Arch. Pharm. Res. 31, 265. O'Brien, K., et al. 2008. J. Biol. Chem. 283, 33147. Yoon, S,O., et al. 2006. Mol. Cancer Ther. 5, 2666. |
Product Information | |
---|---|
CAS number | 548-19-6 |
Form | Yellow solid |
Hill Formula | C₃₂H₂₂O₁₀ |
Chemical formula | C₃₂H₂₂O₁₀ |
Structure formula Image | |
Quality Level | MQ100 |
Biological Information | |
---|---|
Purity | ≥98% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalog Number | GTIN |
416154-10MG | 04055977187786 |
Documentation
Pre-mRNA Splicing Inhibitor, Isoginkgetin - CAS 548-19-6 - Calbiochem SDS
Title |
---|
Pre-mRNA Splicing Inhibitor, Isoginkgetin - CAS 548-19-6 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
416154 |
References
Reference overview |
---|
Kim, H.Y., et al. 2008. Arch. Pharm. Res. 31, 265. O'Brien, K., et al. 2008. J. Biol. Chem. 283, 33147. Yoon, S,O., et al. 2006. Mol. Cancer Ther. 5, 2666. |